This study is for people with Type 2 Diabetes (T2D), whose blood sugar levels, known as glycemic control, are not well managed with just diet and exercise. The study compares a drug called retatrutide to a placebo, which is a substance with no active medicine. It will last about 11 months and might include up to 11 visits to the study center. Type 2 Diabetes is when the body does not use insulin properly, leading to high blood sugar levels. Insulin is a hormone that helps sugar enter cells to provide energy. The study aims to see if retatrutide is safe and works well for people with T2D.
- Study lasts about 11 months with up to 11 visits needed.
- Participants should have stable weight and not use insulin or diabetes medicine for 90 days before starting.
- Excludes people with Type 1 Diabetes, recent heart problems, or certain other health conditions.
How understandable was the trial content above?
Hard to understand
Easy to understand